Exhibit 99.2
WEBMD HEALTH CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2012 | 2011 | 2012 | 2011 | |||||||||||||
Revenue | $ | 112,668 | $ | 141,369 | $ | 219,615 | $ | 272,978 | ||||||||
Cost of operations | 54,243 | 51,152 | 107,714 | 99,601 | ||||||||||||
Sales and marketing | 31,822 | 32,270 | 61,925 | 64,564 | ||||||||||||
General and administrative | 21,746 | 22,006 | 50,768 | 44,827 | ||||||||||||
Depreciation and amortization | 6,713 | 6,724 | 13,643 | 13,148 | ||||||||||||
Interest income | 34 | 51 | 45 | 67 | ||||||||||||
Interest expense | 5,832 | 5,833 | 11,668 | 8,974 | ||||||||||||
Gain on investments | — | 1,769 | 8,074 | 15,829 | ||||||||||||
Other expense | 1,097 | — | 2,297 | 53 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
(Loss) income from continuing operations before income tax (benefit) provision | (8,751 | ) | 25,204 | (20,281 | ) | 57,707 | ||||||||||
Income tax (benefit) provision | (2,649 | ) | 11,003 | (6,402 | ) | 23,961 | ||||||||||
|
|
|
|
|
|
|
| |||||||||
(Loss) income from continuing operations | (6,102 | ) | 14,201 | (13,879 | ) | 33,746 | ||||||||||
Income from discontinued operations, net of tax | 508 | 7,394 | 508 | 7,394 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net (loss) income | $ | (5,594 | ) | $ | 21,595 | $ | (13,371 | ) | $ | 41,140 | ||||||
|
|
|
|
|
|
|
| |||||||||
Basic (loss) income per common share: | ||||||||||||||||
(Loss) income from continuing operations | $ | (0.12 | ) | $ | 0.24 | $ | (0.26 | ) | $ | 0.58 | ||||||
Income from discontinued operations | 0.01 | 0.13 | 0.01 | 0.12 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net (loss) income | $ | (0.11 | ) | $ | 0.37 | $ | (0.25 | ) | $ | 0.70 | ||||||
|
|
|
|
|
|
|
| |||||||||
Diluted (loss) income per common share: | ||||||||||||||||
(Loss) income from continuing operations | $ | (0.12 | ) | $ | 0.23 | $ | (0.26 | ) | $ | 0.55 | ||||||
Income from discontinued operations | 0.01 | 0.13 | 0.01 | 0.13 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net (loss) income | $ | (0.11 | ) | $ | 0.36 | $ | (0.25 | ) | $ | 0.68 | ||||||
|
|
|
|
|
|
|
| |||||||||
Weighted-average shares outstanding used in computing (loss) income per common share: | ||||||||||||||||
Basic | 49,615 | 58,096 | 52,692 | 58,140 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Diluted | 49,615 | 60,236 | 52,692 | 60,473 | ||||||||||||
|
|
|
|
|
|
|
|
WEBMD HEALTH CORP.
CONSOLIDATED SUPPLEMENTAL FINANCIAL INFORMATION
(In thousands, unaudited)
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2012 | 2011 | 2012 | 2011 | |||||||||||||
Revenue | ||||||||||||||||
Public portal advertising and sponsorship | $ | 93,744 | $ | 121,108 | $ | 181,520 | $ | 231,471 | ||||||||
Private portal services | 18,924 | 20,261 | 38,095 | 41,507 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
$ | 112,668 | $ | 141,369 | $ | 219,615 | $ | 272,978 | |||||||||
|
|
|
|
|
|
|
| |||||||||
Earnings before interest, taxes, non-cash and other items | $ | 14,238 | $ | 45,289 | $ | 25,489 | $ | 83,147 | ||||||||
Interest, taxes, non-cash and other items (b) | ||||||||||||||||
Interest income | 34 | 51 | 45 | 67 | ||||||||||||
Interest expense | (5,832 | ) | (5,833 | ) | (11,668 | ) | (8,974 | ) | ||||||||
Income tax benefit (provision) | 2,649 | (11,003 | ) | 6,402 | (23,961 | ) | ||||||||||
Depreciation and amortization | (6,713 | ) | (6,724 | ) | (13,643 | ) | (13,148 | ) | ||||||||
Non-cash stock-based compensation | (9,381 | ) | (9,348 | ) | (26,281 | ) | (19,161 | ) | ||||||||
Gain on investments | — | 1,769 | 8,074 | 15,829 | ||||||||||||
Other expense | (1,097 | ) | — | (2,297 | ) | (53 | ) | |||||||||
|
|
|
|
|
|
|
| |||||||||
(Loss) income from continuing operations | (6,102 | ) | 14,201 | (13,879 | ) | 33,746 | ||||||||||
Income from discontinued operations, net of tax | 508 | 7,394 | 508 | 7,394 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net (loss) income | $ | (5,594 | ) | $ | 21,595 | $ | (13,371 | ) | $ | 41,140 | ||||||
|
|
|
|
|
|
|
|
(a) | See Annex A-Explanation of Non-GAAP Financial Measures. |
(b) | Reconciliation of Adjusted EBITDA to net (loss) income. |
WEBMD HEALTH CORP.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, unaudited)
June 30, 2012 | December 31, 2011 | |||||||
Assets | ||||||||
Cash and cash equivalents | $ | 964,226 | $ | 1,121,217 | ||||
Accounts receivable, net | 96,834 | 121,335 | ||||||
Prepaid expenses and other current assets | 16,933 | 12,690 | ||||||
Deferred tax assets | 21,872 | 20,482 | ||||||
|
|
|
| |||||
Total current assets | 1,099,865 | 1,275,724 | ||||||
Property and equipment, net | 65,193 | 57,139 | ||||||
Goodwill | 202,104 | 202,104 | ||||||
Intangible assets, net | 18,686 | 19,999 | ||||||
Deferred tax assets | 52,816 | 55,017 | ||||||
Other assets | 28,875 | 31,042 | ||||||
|
|
|
| |||||
Total Assets | $ | 1,467,539 | $ | 1,641,025 | ||||
|
|
|
| |||||
Liabilities and Stockholders’ Equity | ||||||||
Accrued expenses | $ | 49,322 | $ | 55,238 | ||||
Deferred revenue | 89,285 | 88,055 | ||||||
Liabilities of discontinued operations | 1,506 | 1,506 | ||||||
|
|
|
| |||||
Total current liabilities | 140,113 | 144,799 | ||||||
2.25% convertible notes due 2016 | 400,000 | 400,000 | ||||||
2.50% convertible notes due 2018 | 400,000 | 400,000 | ||||||
Other long-term liabilities | 22,942 | 21,790 | ||||||
Stockholders’ equity | 504,484 | 674,436 | ||||||
|
|
|
| |||||
Total Liabilities and Stockholders’ Equity | $ | 1,467,539 | $ | 1,641,025 | ||||
|
|
|
|
WEBMD HEALTH CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)
Six Months Ended June 30, | ||||||||
2012 | 2011 | |||||||
Cash flows from operating activities: | ||||||||
Net (loss) income | $ | (13,371 | ) | $ | 41,140 | |||
Adjustments to reconcile net (loss) income to net cash provided by operating activities: | ||||||||
Income from discontinued operations, net of tax | (508 | ) | (7,394 | ) | ||||
Depreciation and amortization | 13,643 | 13,148 | ||||||
Non-cash interest, net | 2,163 | 1,599 | ||||||
Non-cash stock-based compensation | 26,281 | 19,161 | ||||||
Deferred income taxes | (6,870 | ) | 4,423 | |||||
Gain on investments | (8,074 | ) | (15,829 | ) | ||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | 24,501 | 19,234 | ||||||
Prepaid expenses and other, net | (4,469 | ) | (2,103 | ) | ||||
Accrued expenses and other long-term liabilities | (9,128 | ) | 4,765 | |||||
Deferred revenue | 1,230 | (1,044 | ) | |||||
|
|
|
| |||||
Net cash provided by continuing operations | 25,398 | 77,100 | ||||||
Net cash used in discontinued operations | — | (136 | ) | |||||
|
|
|
| |||||
Net cash provided by operating activities | 25,398 | 76,964 | ||||||
Cash flows from investing activities: | ||||||||
Proceeds received from ARS option | 9,269 | 16,561 | ||||||
Purchases of property and equipment | (16,606 | ) | (9,557 | ) | ||||
|
| �� |
|
| ||||
Net cash (used in) provided by investing activities | (7,337 | ) | 7,004 | |||||
Cash flows from financing activities: | ||||||||
Proceeds from exercise of stock options | 816 | 25,053 | ||||||
Cash used for withholding taxes due on stock-based awards | (1,958 | ) | (6,632 | ) | ||||
Net proceeds from issuance of the 2.50% Notes and 2.25% Notes | — | 774,745 | ||||||
Purchases of treasury stock | (173,910 | ) | (150,417 | ) | ||||
Excess tax benefit on stock-based awards | — | 17,843 | ||||||
|
|
|
| |||||
Net cash (used in) provided by financing activities | (175,052 | ) | 660,592 | |||||
|
|
|
| |||||
Net (decrease) increase in cash and cash equivalents | (156,991 | ) | 744,560 | |||||
Cash and cash equivalents at beginning of period | 1,121,217 | 400,501 | ||||||
|
|
|
| |||||
Cash and cash equivalents at end of period | $ | 964,226 | $ | 1,145,061 | ||||
|
|
|
|